These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7478407)
21. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Hwang K; Park CH; Kim HC; Kim H; Yoon S; Pai M; Kim S Clin Nucl Med; 2000 Oct; 25(10):789-95. PubMed ID: 11043718 [TBL] [Abstract][Full Text] [Related]
22. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma. Mouratidis B; Gilday DL; Ash JM Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402 [TBL] [Abstract][Full Text] [Related]
23. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Stumpe KD; Urbinelli M; Steinert HC; Glanzmann C; Buck A; von Schulthess GK Eur J Nucl Med; 1998 Jul; 25(7):721-8. PubMed ID: 9662594 [TBL] [Abstract][Full Text] [Related]
24. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Yang CC; Sun SS; Lin CC; Kao CH; Lee CC Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545 [TBL] [Abstract][Full Text] [Related]
25. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. Okada J; Yoshikawa K; Imazeki K; Minoshima S; Uno K; Itami J; Kuyama J; Maruno H; Arimizu N J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808 [TBL] [Abstract][Full Text] [Related]
26. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420 [TBL] [Abstract][Full Text] [Related]
27. Value of thallium-201 scintigraphy for primary tumour detection in patients with malignant neck masses. Güney E; Yiğitbaşi OG; Tutus A; Bozdemir K; Nardali M Eur J Nucl Med; 1998 Apr; 25(4):431-4. PubMed ID: 9553174 [TBL] [Abstract][Full Text] [Related]
28. [Abdominal ultrasound diagnosis of malignant lymphomas]. Plat M; Erk JU Gastroenterol J; 1990; 50(3):117-23. PubMed ID: 2288652 [TBL] [Abstract][Full Text] [Related]
29. [Radiological diagnostics of Hodgkin- and non-Hodgkin lymphomas of the thorax]. Uffmann M; Schaefer-Prokop C Radiologe; 2004 May; 44(5):444-56. PubMed ID: 15114475 [TBL] [Abstract][Full Text] [Related]
30. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. Moog F; Kotzerke J; Reske SN J Nucl Med; 1999 Sep; 40(9):1407-13. PubMed ID: 10492357 [TBL] [Abstract][Full Text] [Related]
31. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065 [TBL] [Abstract][Full Text] [Related]
32. Similar pelvic abnormalities on FDG positron emission tomography of different origins. Zhuang H; Yamamoto AJ; Sinha P; Pourdehnad M; Liu Y; Alavi A Clin Nucl Med; 2001 Jun; 26(6):515-7. PubMed ID: 11353298 [TBL] [Abstract][Full Text] [Related]
33. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408 [TBL] [Abstract][Full Text] [Related]
34. [Computed tomographic diagnosis of malignant lymphoma of the thorax]. Bautz W Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1986; 125():95-110. PubMed ID: 2877638 [No Abstract] [Full Text] [Related]
35. [The diagnosis of malignant lymphoma of the thorax: the value of CT in comparison with thoracic radiography--an evaluation study]. Bautz W; Klier R; Lenz M Rontgenpraxis; 1993 May; 46(5):124-30. PubMed ID: 8516718 [No Abstract] [Full Text] [Related]
36. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma. Afaq A; Fraioli F; Sidhu H; Wan S; Punwani S; Chen SH; Akin O; Linch D; Ardeshna K; Lambert J; Miles K; Groves A; Kayani I Clin Nucl Med; 2017 Jan; 42(1):e1-e7. PubMed ID: 27607161 [TBL] [Abstract][Full Text] [Related]
37. [Clinical x-ray comparisons in the intrathoracic localization of lymphogranulomatosis and non-Hodgkin lymphomas]. Simbirtseva LP; Shedakov AA; Shust VF; Davydova SB Vopr Onkol; 1986; 32(1):50-5. PubMed ID: 3753812 [TBL] [Abstract][Full Text] [Related]
39. Contribution of computed tomography to the treatment of lymphomas. Pilepich MV; Rene JB; Munzenrider JE; Carter BL AJR Am J Roentgenol; 1978 Jul; 131(1):69-73. PubMed ID: 97988 [TBL] [Abstract][Full Text] [Related]
40. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]